cnbc.com/2022/01/14/pharma-bro-martin-shkreli-banned-for-life-from-drug-industry-ordered-to-pay-64point6-million.html
Martin Shkreli is ordered to pay $64.6 million in profits he earned from hiking the price of the drug Daraprim. The ruling came in response to a lawsuit against the incarcerated "Pharma Bro" by the Federal Trade Commission, and several states, including New York and California.

Martin Shkreli must pay $64.6 million in profits he earned from hiking the price of the life-saving drug Daraprim. The 135-page ruling in U.S. District Court in Manhattan came in response to a lawsuit alleging illegal and monopolistic behavior by the incarcerated fraudster.

Shkreli "initiated a scheme to block the entry of generic drug competition," the judge says. Cote presided over a seven-day trial in the case last month without a jury. The trial is expected to last at least a few more weeks.

Vyera had been known as Turing Pharmaceuticals when Shkreli ordered the massive price hike for the drug in 2015. The price hike earned him widespread condemnation at the time from a wide range of people, including former President Donald Trump and then-Democratic presidential contender Hillary Clinton. The outrage led to the sobriquet "Pharma Bro"
Tap to copy the Short Url to this post:
bto.sh/ka6w7n55 
All Business News on a Single Page. Join for Free →